LifeStance Health Group, Inc.
For the period ended Dec 31, 2025. Filed Feb 25, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Feb 25, 2026
LFST$14.56-0.3%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Changes in Stockholders' Equity
(In thousands)
| Common Stock · AdditionalPaid-in · Accumulated Other Comprehensive · Accumulated · Total Stockholders' | ||||||
|---|---|---|---|---|---|---|
| Shares | Amount | Capital | Income | Deficit | Equity | |
| Balances at December 31, 2022 | 375,964 | $3,761 | $2,084,324 | $3,274 | $(572,636) | $1,518,723 |
| Net loss | — | — | — | — | (186,262) | (186,262) |
| Adoption of ASU 2016-13 | — | — | — | — | (1,948) | (1,948) |
| Issuance of common stock upon vesting of restricted stock units | 4,831 | 48 | (48) | — | — | — |
| Forfeitures | (2,070) | (20) | (3,379) | — | — | (3,399) |
| Other comprehensive loss | — | — | — | (971) | — | (971) |
| Stock-based compensation expense | — | — | 102,787 | — | — | 102,787 |
| Balances at December 31, 2023 | 378,725 | $3,789 | $2,183,684 | $2,303 | $(760,846) | $1,428,930 |
| Net loss | — | — | — | — | (57,443) | (57,443) |
| Issuance of common stock upon vesting of restricted stock units | 7,221 | 71 | (71) | — | — | — |
| Forfeitures | (3,211) | (33) | 33 | — | — | — |
| Other comprehensive loss | — | — | — | (1,374) | — | (1,374) |
| Stock-based compensation expense | — | — | 76,172 | — | — | 76,172 |
| Balances at December 31, 2024 | 382,735 | $3,827 | $2,259,818 | $929 | $(818,289) | $1,446,285 |
| Net income | — | — | — | — | 9,663 | 9,663 |
| Issuance of common stock upon vesting of restricted stock units | 6,570 | 66 | (8,771) | — | — | (8,705) |
| Forfeitures | (987) | (10) | 10 | — | — | — |
| Other comprehensive loss | — | — | — | (929) | — | (929) |
| Stock-based compensation expense | — | — | 74,701 | — | — | 74,701 |
| Balances at December 31, 2025 | 388,318 | $3,883 | $2,325,758 | $— | $(808,626) | $1,521,015 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.